跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,839 条关于
“KRAS(G12D)”
全部
1,839
临床试验
1,161
药物
239
机构
1
资讯
438
2年前
AstraZeneca Secures KRAS G12D Inhibitor in $419M Deal with Usynova
去年
Daraxonrasib and Zoldonrasib Show Promise in RAS-Mutated Pancreatic Cancer
去年
Revolution Medicines Reports Promising Results for Zoldonrasib in KRAS G12D Mutant Lung Cancer
6个月前
JingFang Medicine's GFH375 Receives China's First Breakthrough Therapy Designation for KRAS G12D-Mutated NSCLC
11个月前
HengRui Advances KRAS G12D Inhibitor HRS-4642 to Phase 3 Trial in Pancreatic Cancer
11个月前
First-in-Human Trial Shows Engineered Exosomes Safely Target KRAS G12D in Pancreatic Cancer
6个月前
Incyte Advances KRAS G12D Inhibitor to Phase 3 Despite Fatal Pneumonitis and European Clinical Hold
去年
Quanta Therapeutics Advances KRAS G12D Inhibitor QTX3034 to Dose Expansion Phase Following Positive Safety Data
5个月前
Hengrui Pharma Receives Clinical Trial Approvals for Five Oncology Drugs Including Novel KRAS G12D Inhibitor
上个月
GenFleet's Oral KRAS G12D Inhibitor GFH375 Enters Registrational Phase III Trial in NSCLC, First of Its Kind Globally
第 1 页,共 44 页
上一页
下一页